Morgan Stanley making cautious comments; Reiterates Underweight rating, price target $80
- Firm sees more downsiderisk to the Ocalivaaction date given the high expectations forapproval. Additionally, pricing risks and launch skepticism could pressure ICPTshares exiting this binary event, offsetting speculation for strategic optionality